Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)

Gottesman, 1993, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu Rev Biochem, 62, 385, 10.1146/annurev.bi.62.070193.002125

Cole SPC, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258, 1650–1654.

Kruh, 1995, Expression pattern of MRP in human tissues and adult solid tumor cell lines, J Natl Cancer Inst, 87, 1256, 10.1093/jnci/87.16.1256

Cole SPC, Sparks KE, Fraser K, et al. Pharmacological characterization of multidrug-resistant MRP-transfected human tumor cells. Cancer Res 1994, 54, 5902–5910.

Breuninger LM, Paul S, Gaughan K, et al. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 1995, 55, 5342–5347.

Loe, 1996, Biology of the multidrug resistance-associated protein, MRP, Eur J Cancer, 32A, 945, 10.1016/0959-8049(96)00046-9

Muller M, Meijer C, Zaman GJR, et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci 1994, 91, 13033–13037.

Paul, 1996, ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter, Proc Natl Acad Sci, 93, 6929, 10.1073/pnas.93.14.6929

Fisher, 1996, Pharmacological considerations in the modulation of multidrug resistance, Eur J Cancer, 32A, 1082, 10.1016/0959-8049(96)00111-6

Versantvoort, 1994, Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells, Biochem Pharmacol, 48, 1129, 10.1016/0006-2952(94)90149-X

Gekeler, 1995, The specific bisindoylmaleimide PKC-inhibitor GF109203X efficiently modulates MRP-associated multiple drug resistance, Biochem Biophys Res Commun, 206, 119, 10.1006/bbrc.1995.1017

Gekeler, 1995, The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance, Biochem Biophys Res Commun, 208, 345, 10.1006/bbrc.1995.1344

Gollapudi, 1995, Difloxacin reverses multidrug resistance in HL60/AR cells that overexpress the multidrug resistance-related protein (MRP) gene, Oncology Res, 7, 213

Amin AR, Vyas P, Attur M, et al. The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci 1995, 92, 7926–7930.

Alberts DS, Hixson L, Ahnen D, et al. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J Cell Biochem 1994 S22, 18–23.

Furuta, 1988, Increase in radioresponse of murine tumors by treatment with indomethacin, Cancer Res, 48, 3008

Powles, 1978, Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of PG synthesis, Biochem Pharmacol, 27, 1389, 10.1016/0006-2952(78)90127-2

Bennett, 1987, Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate, Br J Pharmac, 91, 229, 10.1111/j.1476-5381.1987.tb09003.x

Gaffen, 1989, The effects of dipyrimadole and indomethacin on methotrexate cytotoxicity in LoVo colon cancer cells, J Pharm Pharmacol, 41, 350, 10.1111/j.2042-7158.1989.tb06473.x

Teicher, 1994, Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies, Cancer Chemother Pharmacol, 33, 515, 10.1007/BF00686511

Kobayashi, 1997, Indomethacin enhances the cytotoxicity of VCR and ADR in human pulmonary adenocarcinoma cells, Tohoku J Exp Med, 181, 361, 10.1620/tjem.181.361

Draper, 1997, Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein, Br J Cancer, 75, 810, 10.1038/bjc.1997.145

Law, 1992, Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines, Cancer Genet Cytogenet, 59, 111, 10.1016/0165-4608(92)90204-L

Clynes, 1992, Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A, Cytotechnology, 10, 75, 10.1007/BF00376102

Hucker HB, Stauffer SC, White SD, et al. Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Drug Metab Disposition 1973, 1(6), 721–736.

Martin, 1991, Acid phosphatase: endpoint for in vitro toxicity tests, In vitro Cell Develop Biol, 27A, 183, 10.1007/BF02630912

Martin, 1993, Comparison of 5 microplate colorimetric assays for in vitro cytotoxicity testing and cell proliferation assays, Cytotechnology, 11, 49, 10.1007/BF00749057

Ishikawa, 1994, GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation, J Biol Chem, 269, 29085, 10.1016/S0021-9258(19)62016-8

Habig, 1981, Glutathione S-transferases (rat and human), Methods Enzymol, 77, 218, 10.1016/S0076-6879(81)77029-0

Smith P, Krohn R, Hermanson G, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150, 76–85.

Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0

Towbin, 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedures and some applications, Proc Natl Acad Sci, 76, 4350, 10.1073/pnas.76.9.4350

Moran E, Cleary I, Larkin AM, et al. Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42. Eur J Cancer 1997, 33(4), 652–660.

Chou, 1983, Analysis of combined drug effects: a new look at a very old problem, Trends Pharmacol Sci, 4, 450, 10.1016/0165-6147(83)90490-X

Barrand, 1994, A 190k protein overexpressed in non-P-glycoprotein containing MDR cells and its relation to the MRP gene, J Natl Cancer Inst, 86, 110, 10.1093/jnci/86.2.110

Zhu, 1994, Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin, Cancer Res, 54, 4488

Berger, 1997, Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small cell lung cancer cells, Int J Cancer, 73, 84, 10.1002/(SICI)1097-0215(19970926)73:1<84::AID-IJC14>3.0.CO;2-5

Jedlitschky, 1994, ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein, Cancer Res, 54, 4833

Versantvoort, 1995, Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein, Br J Cancer, 72, 82, 10.1038/bjc.1995.281

Hall, 1989, Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell line, Cancer Res, 49, 6265

Mosialou, 1990, Inhibition studies on rat liver microsomal glutathione transferase, Chem-Biol Interactions, 74, 275, 10.1016/0009-2797(90)90044-N

Dixon, 1984, Rapid method for the determination of either piroxicam or tenoxicam in plasma using high performance liquid chromatography, J Chromatog, 310, 455, 10.1016/0378-4347(84)80116-4

Johnson, 1992, Improved high-performance liquid chromatographic method for the determination of indomethacin in plasma, Therapeutic Drug Monitoring, 14, 61, 10.1097/00007691-199202000-00010

Zaman GJR, Lankelma J, Van Tellingen O, et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci 1995, 92, 7690–7694.

Kerbel, 1996, Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors, Hum Cell, 9, 257

Flens M, Izquierdo MA, Scheffer GL, et al. Immunochemical detection of the multidrug resistance-associated protein (MRP) in tumor cells by monoclonal antibodies. Cancer Res 1994, 54, 4557–4563.

Flens M, Zaman GJR, Van der Valk P, et al. Tissue distribution of the multidrug resistance protein. Am J Pathol 1994, 148, 1237–1247.

Zhan Z, Sandor VA, Gamelin E, et al. Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay. Blood 1997, 89(10), 3795–3800.

Kubo H, Sumizawa T, Koga K, et al. Expression of multidrug resistance-associated protein (MRP) gene in urothelial carcinomas. Int J Cancer 1996, 69(6), 488–494.

Kool M, Haas M de, Scheffer GL, et al. Analysis of expression of cMOAT(MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 1997, 57(16), 3537–3547.